Rapport Therapeutics (RAPP) Plunges 5.07% After Reaching 2025 High
Generated by AI AgentAinvest Movers Radar
Friday, Jul 11, 2025 6:45 pm ET1min read
RAPP--
Rapport Therapeutics (RAPP) shares experienced a significant decline, dropping by 5.07% today. The stock price reached its highest level since February 2025, with an intraday gain of 2.08%.
The strategy of buying RAPPRAPP-- shares after they reach a recent high and selling them one week later delivered moderate returns but came with significant volatility and risk. The strategy’s CAGR was 1.94% with an excess return of 102.09% relative to the benchmark, which had a return of -100.00%. However, the strategy had a maximum drawdown of 0.00% and a Sharpe ratio of 0.02, indicating it managed risk well but offered conservative returns.On July 11, 2025, there was no relevant information regarding the causes of changes in Rapport TherapeuticsRAPP-- (RAPP) stock price according to the criteria provided.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments

No comments yet